News|Webcasts|July 31, 2023
Driving Down Development Timelines Through Optimized Clinical Outsourcing Strategies and Flexible Operating Models
Author(s)IQVIA
Webinar Date/Time: Tuesday, September 26th, 2023 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST
Advertisement
How FSP is changing the way studies are outsourced, an investigation into the history, trends and key drivers of success for using functional service providers.
Event Overview:
Ongoing challenges with cost and time-to-market have created increasing pressures for sponsors to optimize their clinical trial delivery. This webinar explores some of the key headwinds for clinical trial delivery in addition to the tools, technologies and processes that are being leveraged to address these. The evolution of outsourcing strategies is discussed along with a focus on diverse Functional Service Provider (FSP) models.
These FSP delivery models will be discussed, looking at how they can be leveraged to address specific needs and requirements, their pros and cons, as well as the key deciding factors for how and when they should be employed.
Key take-aways
These FSP delivery models will be discussed, looking at how they can be leveraged to address specific needs and requirements, their pros and cons, as well as the key deciding factors for how and when they should be employed.
Key take-aways
- How the industry approach to FSP is shifting and its impact on development costs and timelines
- Which levers can be employed to mitigate the increasing costs and timelines for clinical trial delivery
- How changes in outsourcing strategies are focusing on flexible delivery models
- Not ‘one-size fits all’. How to identify optimal FSP strategies for your situation. Deep dive into the different types of FSP models, their pros and cons
- How to set up and implement a successful FSP model
Speakers:
Ian Pemberton
VP, Clinical FSP
IQVIA
Ian has over 26 years in clinical research and has worked in Pharma Companies and CROs in that time in a number of operational and leadership roles. Ian has spent the last 16 years working in IQVIA in Clinical, Project Management, Regulatory & Start up roles with the last 3 years leading the setup, implementation and oversight of Clinical FSP Models.
Stephen Evans
VP, Clinical FSP
IQVIA
Stephen leads IQVIA’s large pharma clinical FSP group. He has spent 15 years at IQVIA across a number of clinical development and business development roles and immediately prior to working in Clinical FSP he led IQVIA’s Early Clinical Development unit within Project Leadership.
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Articles
- Q&A: Strategies for Successful Global Clinical Trial Delivery
September 12th 2025
- How ClinOps Teams Should Evaluate GenAI Tools in Trial Discovery
September 11th 2025
- eClinical Technology: Misconceptions, Challenges, and Opportunities
September 9th 2025
- How Sponsors Can Modernize Tools to Support Physicians
September 9th 2025
- Why Decentralized Trials Face Slow Adoption Despite Strong Data
August 26th 2025
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
FDA Fast Tracks Sanofi’s Intravitreal Gene Therapy for Neovascular Age-Related Macular Degeneration
2
Phase III BRUIN CLL-313 Trial Finds Jaypirca Extends Progression-Free Survival in Treatment-Naïve CLL/SLL
3
Vabysmo Shows Long-Term Efficacy and Safety in Wet AMD, PCV Patients
4
Latest NIMBLE Study Results Highlight Progress in gMG Research
5